Letter to the Editors: Statins and COVID-19: Efficacy Still to Be Proven
Meunier L;Meszaros M;Pageaux GP;;
Hepatology2020pp. -
220
l2020hepatologyletter
Abstract
We read with interest the article by Bloom et al reporting liver biochemistry-associated trends, etiologies, and outcomes in 60 patients with coronavirus disease 2019 (COVID-19). The authors reported that 69% of the patients had abnormal liver function tests (LFTs) on admission and 93% during their …